Loading clinical trials...
Loading clinical trials...
Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy: a Prospective Randomized Controlled Study
Video capsule endoscopy (VCE) has become an established technique to investigate the presence of small bowel pathology. But the limited battery life of capsules can lead to incomplete small bowel visualization. There is a rationale to use prokinetic agents prior to VCE reduce the chances of an incomplete small bowel examination via decrease gastric transit time (GTT). Investigators are aimed to prospectively compare the completion rate of VCE in pediatric patients receiving prokinetic with those receiving no prokinetic.
Eligible children were randomly divided into two groups: domperidone prior to VCE and water prior to VCE. The primary outcome measure was the completion rate. Secondary outcome measures included the GTT and SBTT.
Age
3 - 18 years
Sex
ALL
Healthy Volunteers
No
Children's hospital of Fudan university
Shanghai, Shanghai Municipality, China
Start Date
November 1, 2017
Primary Completion Date
November 1, 2018
Completion Date
November 1, 2018
Last Updated
December 17, 2018
200
ACTUAL participants
Domperidone
DRUG
water
DIETARY_SUPPLEMENT
Lead Sponsor
Children's Hospital of Fudan University
NCT06464757
NCT06489951
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions